Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Resources, news and special offers to support you and your professional development during this difficult time.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Download your copy of the new events calendar and see all the online workshops, conferences, RAC exams and European online workshops RAPS has planned for 2021 at a glance.
Registration is now open for RAPS Euro Convergence 2021! Attend to join peers from EU and around the world to gain insights and exchange ideas on the regions most pressing issues.
An invaluable resource for any professional engaged in designing, composing, compiling, or commenting on regulatory documentation
From self-assessments to help you identify your strengths and areas to focus on to reference books and online courses that will help you fill in the gaps in your regulatory knowledge, RAPS has the resources to help you prepare for the RAC exam.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Posted 02 May 2012 | By Alexander Gaffney, RAC
Health Canada plans to get rid of its Schedule F drug regulations which govern which drugs may be sold over-the-counter (OTC) and which require a physician's prescription to purchase.
The change is due to the onerous process by which drugs are added and removed to the schedule, which Health Canada said can take upwards of 20 months, even after regulators have determined the product is safe for consumers to purchase and use on their own.
The delay, caused because a regulatory amendment is necessary to make the addition or subtraction to the Schedule F list, has delayed OTC drugs from reaching consumers, noted Health Canada.
The change could see drugs reaching consumers nearly two years faster and save Health Canada time and resources, said Minister of Health Leona Aglukkaq in a statement.
"This proposal also means taxpayers will no longer have to cover the costs of outdated regulatory processes," said Minister Aglukkaq. "Health Canada will replace the current inefficient process with a faster and transparent posting of each new prescription drug on our website."
Read more:
Health Canada - Harper Government Cuts Red Tape that Delays Access to Over-the-Counter Drugs
Pharma Times - Canada to speed access to OTCs
Tags: Schedule F, Aglukkaq, OTC, Latest News, pharmaceutical, drug
Regulatory Focus newsletters
All the biggest regulatory news and happenings.